BSc, MBL, GAICD. Board Director.  Catherine has more than 30 years’ experience as a pharmaceutical, biotechnology and medical technology executive having held senior roles in corporate, medical, commercialisation and business development. 

Catherine’s skills and experience encompass research, regulatory and pricing approvals, licensing, strategy, business development, project management, product development, operations excellence, partnerships, and capital raising.

Catherine’s prior experience was as General Manager and Chief Operating Officer in the emergent medical cannabis industry and has worked in pharmaceutical companies such as Mundipharma, Allergan (now part of AbbVie), Nycomed (now Takeda) and Roche Products in roles working across prescription and OTC products, as well as medical devices.